|Bid||2.45 x 300|
|Ask||3.50 x 500|
|Day's Range||2.55 - 2.75|
|52 Week Range||2.10 - 4.45|
|PE Ratio (TTM)||-1.12|
|Earnings Date||Nov 13, 2017 - Nov 17, 2017|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||76.00|
On a per-share basis, the San Diego-based company said it had a loss of 51 cents. In the final minutes of trading on Monday, the company's shares hit $3.25. A year ago, they were trading at $3.42. _____ ...
–Resolaris Demonstrated Favorable Safety Profile in Rare Muscular Dystrophy Patients in Extension Studies–– iMod.Fc Program for Interstitial Lung Disease on Track to Commence Phase 1 Clinical Trial–– Project ...
SAN DIEGO, Aug. 10, 2017-- aTyr Pharma, Inc., a biotherapeutics company engaged in the discovery and development of Physiocrine-based therapeutics to address severe, rare diseases, will report its financial ...